Evidence map›Paper›PMID 12941135›Full record

ReviewImmunology2003

Facets of heat shock protein 70 show immunotherapeutic potential.

Stephen M Todryk, Michael J Gough, A Graham Pockley

Open access · bronzeAbstract readReview
In one paragraph

Review in Immunology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 112 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. HSP70: an alarmin that does not induce high rates of preterm birth but does cause adverse neonatal outcomes.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2021
    Article
  5. Article
  6. HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development.Archivum immunologiae et therapiae experimentalis · 2020
    Review
  7. Article
  8. Article
  9. Review
  10. Role of the Immune System in Hypertension.Physiological reviews · 2017
    Review
  11. Review
  12. Article
  13. Article
  14. Autoimmunity in the pathogenesis of hypertension.Nature reviews. Nephrology · 2014
    Review
  15. Article
  16. Article
  17. Review
  18. Mini-chaperones: potential immuno-stimulators in vaccine design.Human vaccines & immunotherapeutics · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Stephen M TodrykImmune Regulation Research Group, Department of Biochemistry, Trinity College, Dublin, Ireland. todryks@tcd.ie
Michael J Gough
A Graham Pockley
Trinity College Dublin · IE

Funding

Modulation of Cell Death during Cytotoxic Gene TherapyR01CA094180 · NCI · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI VILE, RICHARD G · 2002 to 2004
$772k
NCI NIH HHS R01 CA 094180NCI NIH HHS R01 CA094180
6 · The paper itself

Abstract

Amongst the families of intracellular molecules that chaperone and assist with the trafficking of other proteins, notably during conditions of cellular stress, heat shock protein (hsp) 70 is one of the most studied. Although its name suggests that expression is exclusively induced during cellular hyperthermia, members of the hsp70 family of proteins can be constitutively expressed and/or induced by a range of other cellular insults. The ubiquitous presence of hsp70 in eukaryotic and prokaryotic cells, combined with its high degree of sequence homology and intrinsic immunogenicity, have prompted the suggestion that inappropriate immune reactivity to hsp70 might lead to pro-inflammatory responses and the development of autoimmune disease. Indeed, hsp70 has been shown to be a potent activator of innate immunity and aberrant expression of hsp70 in certain organs promotes immunopathology. However, studies also suggest that hsp70 might have immunotherapeutic potential, as hsp70 purified from malignant and virally infected cells can transfer and deliver antigenic peptides to antigen-presenting cells to elicit peptide-specific immunity and, in contrast to its reported pro-inflammatory effects, the administration of recombinant hsp70 can attenuate experimental autoimmune disease. This review focuses on the immunoregulatory capacity of hsp70 and its potential therapeutic value.

Indexed as

Antigen PresentationAutoimmunityHSP70 Heat-Shock ProteinsHumansImmunotherapyNeoplasmsHSP70 Heat-Shock Proteins

Identifiers

PMID12941135
PMCPMC1783014
OpenAlexW2027047709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.